PT2415463E - Composição medicinal em partículas - Google Patents
Composição medicinal em partículas Download PDFInfo
- Publication number
- PT2415463E PT2415463E PT117112425T PT11711242T PT2415463E PT 2415463 E PT2415463 E PT 2415463E PT 117112425 T PT117112425 T PT 117112425T PT 11711242 T PT11711242 T PT 11711242T PT 2415463 E PT2415463 E PT 2415463E
- Authority
- PT
- Portugal
- Prior art keywords
- medicinal composition
- particulate medicinal
- particulate
- composition
- medicinal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010029486A JP4653242B1 (ja) | 2010-02-12 | 2010-02-12 | 粒子状医薬組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2415463E true PT2415463E (pt) | 2016-03-22 |
Family
ID=43952737
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT117112425T PT2415463E (pt) | 2010-02-12 | 2011-02-14 | Composição medicinal em partículas |
| PT151597952T PT2918267T (pt) | 2010-02-12 | 2011-02-14 | Composições farmacêuticas em partículas |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT151597952T PT2918267T (pt) | 2010-02-12 | 2011-02-14 | Composições farmacêuticas em partículas |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9198860B2 (pt) |
| EP (2) | EP2415463B1 (pt) |
| JP (1) | JP4653242B1 (pt) |
| KR (2) | KR101839545B1 (pt) |
| CN (1) | CN102753151B (pt) |
| AU (1) | AU2011215177B2 (pt) |
| CA (1) | CA2785858C (pt) |
| DK (2) | DK2415463T3 (pt) |
| ES (2) | ES2636778T3 (pt) |
| PL (2) | PL2415463T3 (pt) |
| PT (2) | PT2415463E (pt) |
| WO (1) | WO2011099601A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9808480B2 (en) | 2012-04-27 | 2017-11-07 | Nanocarrier Co., Ltd. | Unit structure-type pharmaceutical composition for nucleic acid delivery |
| WO2016137006A1 (ja) * | 2015-02-27 | 2016-09-01 | ナノキャリア株式会社 | ポリマーミセル担体組成物およびポリマーミセル組成物 |
| WO2019044937A1 (ja) | 2017-08-31 | 2019-03-07 | 国立大学法人 東京大学 | 核酸搭載ユニット型ポリイオンコンプレックス |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02121932A (ja) * | 1988-10-29 | 1990-05-09 | Res Inst For Prod Dev | ヘモグロビン含有リポソーム、その製造方法および該製造方法用の原液 |
| KR940003548U (ko) | 1992-08-14 | 1994-02-21 | 김형술 | 세탁물 건조기 |
| US6884430B1 (en) | 1997-02-10 | 2005-04-26 | Aventis Pharma S.A. | Formulation of stabilized cationic transfection agent(s) /nucleic acid particles |
| FR2759298B1 (fr) | 1997-02-10 | 1999-04-09 | Rhone Poulenc Rorer Sa | Formulation de particules agent(s) de transfection cationique(s)/acides nucleiques stabilisees |
| TWI225412B (en) | 1997-06-23 | 2004-12-21 | Sequus Pharm Inc | Liposome-entrapped polynucleotide composition and method |
| WO1999033489A1 (fr) * | 1997-12-26 | 1999-07-08 | Yamanouchi Pharmaceutical Co., Ltd. | Compositions medicinales a liberation prolongee |
| JP2000302685A (ja) * | 1999-02-18 | 2000-10-31 | Sankyo Co Ltd | 抗腫瘍薬含有リポソーム製剤 |
| DE19954843C2 (de) | 1999-11-09 | 2003-11-20 | Novosom Ag | Verfahren zur Verkapselung von Proteinen oder Peptiden in Liposomen, mit dem Verfahren hergestellte Liposomen und deren Verwendung |
| JP3942362B2 (ja) * | 2000-02-02 | 2007-07-11 | アンジェスＭｇ株式会社 | 遺伝子導入のためのウイルスエンベロープベクター |
| EP1170363B1 (en) | 2000-02-02 | 2007-11-21 | Kaneda, Yasufumi | Virus envelope vector for gene transfer |
| FR2814951B1 (fr) | 2000-10-06 | 2003-01-17 | Flamel Tech Sa | Suspension colloidale de particules submicroniques de vectorisation de principes actifs hydrophiles (insuline) et leur mode de preparation |
| CA2453441C (en) | 2001-07-13 | 2011-10-18 | Nanocarrier Co., Ltd. | Lyophilizing composition of drug-encapsulating polymer micelle and method for preparation thereof |
| JP4063510B2 (ja) * | 2001-07-13 | 2008-03-19 | ナノキャリア株式会社 | 薬物含有高分子ミセルの凍結乾燥用組成物およびその凍結乾燥製剤 |
| JP4294946B2 (ja) * | 2002-12-13 | 2009-07-15 | 富士フイルム株式会社 | 標的検出装置及び標的検出方法並びに標的検出用基材 |
| AU2003293195A1 (en) * | 2002-12-23 | 2004-07-29 | Vical Incorporated | Method for freeze-drying nucleic acid/block copolymer/cationic surfactant complexes |
| US20090010999A1 (en) | 2004-03-10 | 2009-01-08 | Kyowa Hakko Kogyo Co., Ltd. | Complex Particles and Coated Complex Particles |
| CA2572439A1 (en) | 2004-07-02 | 2006-01-12 | Protiva Biotherapeutics, Inc. | Immunostimulatory sirna molecules and uses therefor |
| WO2006060723A2 (en) * | 2004-12-03 | 2006-06-08 | Vical Incorporated | Methods for producing block copolymer/amphiphilic particles |
| JP2006321763A (ja) * | 2005-05-20 | 2006-11-30 | Hosokawa Funtai Gijutsu Kenkyusho:Kk | 生体適合性ナノ粒子及びその製造方法 |
| JP2007099631A (ja) * | 2005-09-30 | 2007-04-19 | Hosokawa Funtai Gijutsu Kenkyusho:Kk | アニオン性薬物封入ナノ粒子の製造方法及びそれを用いた医薬製剤 |
| CN101331173A (zh) * | 2005-10-05 | 2008-12-24 | 东京Cro株式会社 | 生物相容性嵌段共聚物、其用途和制造方法 |
| WO2007136134A1 (ja) * | 2006-05-23 | 2007-11-29 | Nanocarrier Co., Ltd. | 疎水性薬物内包ポリマーミセルの製造方法 |
| US8147868B2 (en) | 2006-07-18 | 2012-04-03 | Nanocarrier Co., Ltd. | Physiologically active polypeptide- or protein-encapsulating polymer micelles, and method for production of the same |
| WO2008109105A2 (en) * | 2007-03-06 | 2008-09-12 | Flagship Ventures | Methods and compositions for improved therapeutic effects with sirna |
| JP2009200681A (ja) | 2008-02-20 | 2009-09-03 | Seiko Instruments Inc | 近接検出装置および近接検出方法 |
| CN102300556B (zh) * | 2008-12-26 | 2015-04-29 | 株式会社三养生物制药 | 含有阴离子药物的药物组合物及其制备方法 |
-
2010
- 2010-02-12 JP JP2010029486A patent/JP4653242B1/ja not_active Expired - Fee Related
-
2011
- 2011-02-14 KR KR1020167008609A patent/KR101839545B1/ko active IP Right Grant
- 2011-02-14 EP EP11711242.5A patent/EP2415463B1/en not_active Not-in-force
- 2011-02-14 PL PL11711242T patent/PL2415463T3/pl unknown
- 2011-02-14 EP EP15159795.2A patent/EP2918267B1/en not_active Not-in-force
- 2011-02-14 PL PL15159795T patent/PL2918267T3/pl unknown
- 2011-02-14 DK DK11711242.5T patent/DK2415463T3/en active
- 2011-02-14 CN CN201180009063.8A patent/CN102753151B/zh not_active Expired - Fee Related
- 2011-02-14 PT PT117112425T patent/PT2415463E/pt unknown
- 2011-02-14 US US13/122,546 patent/US9198860B2/en not_active Expired - Fee Related
- 2011-02-14 DK DK15159795.2T patent/DK2918267T3/en active
- 2011-02-14 KR KR1020127017814A patent/KR101612876B1/ko not_active IP Right Cessation
- 2011-02-14 AU AU2011215177A patent/AU2011215177B2/en not_active Ceased
- 2011-02-14 ES ES15159795.2T patent/ES2636778T3/es active Active
- 2011-02-14 CA CA2785858A patent/CA2785858C/en not_active Expired - Fee Related
- 2011-02-14 PT PT151597952T patent/PT2918267T/pt unknown
- 2011-02-14 ES ES11711242.5T patent/ES2560810T3/es active Active
- 2011-02-14 WO PCT/JP2011/053052 patent/WO2011099601A1/ja active Application Filing
-
2015
- 2015-11-02 US US14/930,119 patent/US9795563B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011162512A (ja) | 2011-08-25 |
| ES2636778T3 (es) | 2017-10-09 |
| KR20120113754A (ko) | 2012-10-15 |
| AU2011215177B2 (en) | 2015-10-15 |
| EP2918267B1 (en) | 2017-05-10 |
| AU2011215177A1 (en) | 2012-07-05 |
| DK2415463T3 (en) | 2016-04-11 |
| CA2785858A1 (en) | 2011-08-18 |
| EP2415463B1 (en) | 2016-01-13 |
| DK2918267T3 (en) | 2017-07-10 |
| US20160058703A1 (en) | 2016-03-03 |
| KR101612876B1 (ko) | 2016-04-18 |
| EP2918267A1 (en) | 2015-09-16 |
| PL2415463T3 (pl) | 2016-06-30 |
| PT2918267T (pt) | 2017-06-22 |
| KR101839545B1 (ko) | 2018-03-16 |
| US20120076866A1 (en) | 2012-03-29 |
| CN102753151A (zh) | 2012-10-24 |
| ES2560810T3 (es) | 2016-02-22 |
| EP2415463A4 (en) | 2012-02-29 |
| CA2785858C (en) | 2016-04-26 |
| WO2011099601A1 (ja) | 2011-08-18 |
| US9795563B2 (en) | 2017-10-24 |
| CN102753151B (zh) | 2014-08-06 |
| JP4653242B1 (ja) | 2011-03-16 |
| EP2415463A1 (en) | 2012-02-08 |
| KR20160041057A (ko) | 2016-04-15 |
| PL2918267T3 (pl) | 2017-09-29 |
| US9198860B2 (en) | 2015-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1246170A1 (zh) | 藥物組合物 | |
| IL225457A0 (en) | Pharmaceutical composition | |
| RS55566B1 (sr) | Farmaceutska kompozicija | |
| EP2654736A4 (en) | NEW PHARMACEUTICAL COMPOSITION | |
| PT2579858E (pt) | Composição farmacêutica que contém ivabradina | |
| ZA201301920B (en) | Pharmaceutical composition | |
| GB201010453D0 (en) | Pharmaceutical composition | |
| IL226554A (en) | Medicinal preparations containing alisporiovir | |
| IL221501A (en) | Medicinal product containing miramistine | |
| EP2415463A4 (en) | MEDICAL PARTICLE COMPOSITION | |
| GB201001911D0 (en) | Pharmaceutical composition | |
| GB201019775D0 (en) | Pharmaceutical composition | |
| HU1000006D0 (en) | Improved pharmaceutical composition |